Green Leaf Pharmaceutical Group Co., Ltd. is an investment holding company mainly engaged in the development, production, promotion and sale of drugs. The company and its subsidiaries operate through four divisions: oncology Pharmaceuticals, Cardiovascular Pharmaceuticals, Digestive and Metabolic Pharmaceuticals and other divisions. The company's main products include paclitaxel preparations for cancer chemotherapy, injection compounds for radiotherapy of solid tumors, traditional Chinese medicine for the treatment of hyperlipidemia, acarbose capsules for the treatment of type 2 diabetes, and transdermal patches of carbaradine for the treatment of Alzheimer's disease. The products are sold under the brands of Liposu, Simena, Xuezhikang, Maitona, Beshi and so on. The company is also engaged in providing contract research and program development through its subsidiaries. The company mainly operates in mainland China.
CEO： Dianbo Liu
Market： Hong Kong motherboard